IV Busulfex

IV Busulfex Warnings

busulfan

Manufacturer:

Otsuka (Philippines)

Distributor:

Zuellig

Marketer:

Otsuka (Philippines)
Full Prescribing Info
Warnings
Busulfan (IV Busulfex) Injection causes severe and prolonged myelosuppression at the recommended dosage. Hematopoietic progenitor cell transplantation is required to prevent potentially fatal complications of the prolonged myelosuppression (see Myelosuppression under Precautions).
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in